Oral Dehydroepiandrosterone Supplementation can Increase the Testosterone/Epitestosterone Ratio (Technical Briefs) Oral Dehydroepiandrosterone Supplementation can Increase the Testosterone/Epitestosterone Ratio (Technical Briefs)

Oral Dehydroepiandrosterone Supplementation can Increase the Testosterone/Epitestosterone Ratio (Technical Briefs‪)‬

Clinical Chemistry 1999, Feb, 45, 2

    • € 2,99
    • € 2,99

Publisher Description

The availability of endogenous anabolic steroids and their precursors in the form of "dietary supplements" has become widespread in the United States. The popularity of dehydroepiandrosterone (DHEA) arose from a number of reports in the popular press that suggested that the results of a study conducted by Morales et al. (1) characterized DHEA as similar to the mythical fountain of youth. Increased use of DHEA among athletes was reported anecdotally before and during the 1996 Olympic Games, and the International Olympic Committee (IOC) Medical Commission explicitly added the compound to the list of prohibited compounds in December 1996, although it would have been considered prohibited previously under the "related compounds" provision of the list. Other groups testing for steroids have either added DHEA as an example of a prohibited compound or assumed that it did not play a role in their testing program. Some researchers have questioned whether the use of compounds that are precursors of the anabolic steroid testosterone increase testosterone and therefore impact the testosterone/epitestosterone (T/E) ratio. Two studies have reported that no increase in the T/E ratio occurred when DHEA was given (2,3). We report here on the impact of administration of two over-the-counter DHEA preparations on the excretion of several steroids, and a greater than 6:1 dose-dependent increase of the T/E ratio in one individual.

GENRE
Science & Nature
RELEASED
1999
1 February
LANGUAGE
EN
English
LENGTH
9
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SIZE
183.1
KB

More Books by Clinical Chemistry

Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis (Clinical Immunology) Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis (Clinical Immunology)
2004
Clinical Evaluation of Toxi * Prep[Tm]: A Semiautomated Solid-Phase Extraction System for Screening of Drugs in Urine (Drug Monitoring and Toxicology) Clinical Evaluation of Toxi * Prep[Tm]: A Semiautomated Solid-Phase Extraction System for Screening of Drugs in Urine (Drug Monitoring and Toxicology)
1997
Telomerase Detection in Body Fluids. Telomerase Detection in Body Fluids.
2002
Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs) Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs)
2006
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Detection of Circulating Prostate-Specific Antigen-Secreting Cells in Prostate Cancer Patients (Technical Briefs) Detection of Circulating Prostate-Specific Antigen-Secreting Cells in Prostate Cancer Patients (Technical Briefs)
2005